Clinical Trial Update: RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Trauma [Phase 2]

View source ↗

Summary

This Clinical Trial Update notes completion of a Phase 2 study of RESET, a glucocorticoid receptor blocker, as a disease-modifying treatment for major depressiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• RESET (glucocorticoid receptor antagonist)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Major Depressive Disorder, Childhood Trauma | Phase 2 | Status: COMPLETED